Search clinical trials for: Glimepiride 2 mg
Total 25173 results
-
ShireCompletedAttention Deficit Disorder With Hyperactivity
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
University of ReadingWild Blueberry Association of North America (WBANA)CompletedMood | Cognition | AffectUnited Kingdom
-
U.S. Army Medical Research and Development CommandCompletedGingivitis | PlaqueUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
PfizerTerminatedParkinson DiseaseUnited States, Spain, Canada, France, Japan, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Korea, Republic of, China
-
Gulf Regional Research & Educational Services, LLCUnknownMechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesDiabetes Mellitus Type 2United States
-
PfizerCompletedAnkylosing SpondylitisKorea, Republic of, United States, Spain, Taiwan, Canada, Czech Republic, Poland, Hungary, Germany, Russian Federation
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
Boehringer IngelheimCompleted
-
Al B. Benson, III, MDCelgene Corporation; Big Ten Cancer Research ConsortiumCompletedGastric Cancer | Gastro-Esophageal Junction AdenocarcinomaUnited States
-
CelgeneCompletedPhase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedNon-Small Cell Lung Cancer (NSCLC)Germany
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterCompleted
-
EA Pharma Co., Ltd.Completed
-
Merck Sharp & Dohme LLCTerminated
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia, India, Italy, Russian Federation, Spain, Denmark, United Kingdom, Sweden, Belgium, Ireland, Argentina, Hungary, Norway, South Africa, Germany, Croatia, Netherlands, Bulgaria, Australia, Romania
-
TakedaCompletedDiabetes Mellitus | DyslipidemiasGermany
-
University Hospital TuebingenTerminatedType 2 DiabetesGermany
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Taiwan Biotech Co., Ltd.Unknown
-
Medical College of WisconsinRecruitingGlioblastomaUnited States
-
PfizerCompleted
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Bulgaria, Denmark, France, Germany, Hong Kong, Hungary, India, Ireland, Italy, Netherlands, Norway, Poland, South Africa, Sweden, United Kingdom
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
MediBeaconCompleted
-
McNeil ABCompleted
-
King's College LondonUniversity of CambridgeRecruitingAutism Spectrum DisorderUnited Kingdom
-
Bristol-Myers SquibbCompleted
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
MedImmune LLCMedImmune LtdCompletedAsthmaUnited States, Brazil, Bulgaria, Mexico, Peru, Poland, Russian Federation, Argentina, Canada, Colombia
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
GlaxoSmithKlineCompletedHealthy Volunteer Smokers
-
University of AthensCompletedRetinal Vein Occlusion | Vascular Occlusive Disease
-
Shandong UniversityLinyi People's Hospital; Binzhou People's Hospital; Tai'an People's HospitalUnknownPrucalopride Plus Polyethylene Glycol in Bowel Preparation for ColonoscopypChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
Breath of Life International Pharma LtdCompleted
-
Bial - Portela C S.A.Completed
-
ShireCompletedAttention Deficit Disorder With Hyperactivity
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, Mexico, Puerto Rico
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Healthcare PharmaceuticalsRecruitingSpondyloarthritis, AxialBangladesh